SFI
ABBV icon

Siemens Fonds Invest’s AbbVie ABBV Stock Holding History

Siemens Fonds Invest’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.5M Buy
57,804
+860
+2% +$185K 0.71% 25
2026
Q1 		$12.4M Sell
56,944
-862
-1% -$191K 0.71% 20
2025
Q4 		$13.3M Sell
57,806
-6,370
-10% -$1.45M 0.71% 20
2025
Q3 		$14.9M Buy
64,176
+1,620
+3% +$330K 0.81% 17
2025
Q2 		$11.6M Buy
62,556
+3,565
+6% +$663K 0.68% 21
2025
Q1 		$12.4M Sell
58,991
-6,051
-9% -$1.18M 0.85% 18
2024
Q4 		$11.5M Buy
65,042
+4,743
+8% +$872K 0.77% 20
2024
Q3 		$11.9M Sell
60,299
-463
-0.8% -$86.4K 0.95% 15
2024
Q2 		$10.4M Buy
60,762
+430
+0.7% +$71.2K 0.78% 18
2024
Q1 		$11M Sell
60,332
-1,457
-2% -$251K 0.85% 18
2023
Q4 		$9.58M Sell
61,789
-3,613
-6% -$527K 0.78% 24
2023
Q3 		$9.75M Sell
65,402
-5,802
-8% -$852K 0.99% 20
2023
Q2 		$9.55M Sell
71,204
-800
-1% -$117K 0.93% 19
2023
Q1 		$11.5M Sell
72,004
-2,289
-3% -$350K 1.2% 11
2022
Q4 		$12M Sell
74,293
-1,220
-2% -$187K 1.2% 9
2022
Q3 		$10.1M Sell
75,513
-106
-0.1% -$15.2K 1.16% 12
2022
Q2 		$11.6M Sell
75,619
-414
-0.5% -$63.3K 1.23% 12
2022
Q1 		$12.3M Buy
76,033
+354
+0.5% +$51.4K 1% 14
2021
Q4 		$10.3M Sell
75,679
-4,326
-5% -$511K 0.68% 23
2021
Q3 		$8.63M Buy
80,005
+3,298
+4% +$377K 0.58% 25
2021
Q2 		$8.64M Buy
76,707
+1,134
+2% +$128K 1.03% 19
2021
Q1 		$8.18M Sell
75,573
-670
-0.9% -$71.7K 0.79% 40
2020
Q4 		$8.03M Buy
+76,243
New +$7.33M 0.83% 35

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Siemens Fonds Invest's ABBV Position: Q2 2026 in Review

Siemens Fonds Invest increased its AbbVie (ABBV) stake by 1.5% in Q2 2026, buying an estimated $185K and bringing the position to 57,804 shares worth $14.5M. The position accounts for 0.71% of the portfolio, ranked #25.

Siemens Fonds Invest first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. The position peaked at $14.9M in Q3 2025. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Siemens Fonds Invest held 57,804 shares of AbbVie worth $14.5M as of Q2 2026.
  • Siemens Fonds Invest bought 860 AbbVie shares in Q2 2026, an estimated $185K.
  • AbbVie made up 0.71% of Siemens Fonds Invest's portfolio in Q2 2026, its #25 holding.
  • Siemens Fonds Invest first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • Siemens Fonds Invest's AbbVie position peaked at $14.9M in Q3 2025.
  • 4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Siemens Fonds Invest's 13F filing for Q2 2026, filed 14 Aug 2026.